{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:16:16Z","timestamp":1780647376782,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000215"],"award-info":[{"award-number":["82000215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["GSE2658"],"award-info":[{"award-number":["GSE2658"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["GSE31161"],"award-info":[{"award-number":["GSE31161"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["GSE6477(10)"],"award-info":[{"award-number":["GSE6477(10)"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["GSE24080"],"award-info":[{"award-number":["GSE24080"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["GSE83503"],"award-info":[{"award-number":["GSE83503"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["GSE82307"],"award-info":[{"award-number":["GSE82307"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["GSE5900"],"award-info":[{"award-number":["GSE5900"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["YKK21097"],"award-info":[{"award-number":["YKK21097"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.retram.2025.103495","type":"journal-article","created":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T10:13:37Z","timestamp":1736676817000},"page":"103495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identifying potential prognosis markers in relapsed multiple myeloma via integrated bioinformatics analysis and biological experiments"],"prefix":"10.1016","volume":"73","author":[{"given":"Yong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0849-524X","authenticated-orcid":false,"given":"Hua","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.retram.2025.103495_bib0001","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.retram.2025.103495_bib0002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12964-018-0280-8","article-title":"TRPV2-induced Ca(2+)-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma","volume":"16","author":"Bai","year":"2018","journal-title":"Cell Commun Signaling: CCS"},{"issue":"15","key":"10.1016\/j.retram.2025.103495_bib0003","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1182\/blood-2010-04-279596","article-title":"A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value","volume":"116","author":"Walker","year":"2010","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.retram.2025.103495_bib0004","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1182\/blood.2020008734","article-title":"How I treat relapsed multiple myeloma","volume":"139","author":"Kastritis","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103495_bib0005","doi-asserted-by":"crossref","first-page":"12050","DOI":"10.1038\/ncomms12050","article-title":"Genome-wide association study identifies multiple susceptibility loci for multiple myeloma","volume":"7","author":"Mitchell","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.retram.2025.103495_bib0006","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood-2006-07-037077","article-title":"Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis","volume":"109","author":"Zhan","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2025.103495_bib0007","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"Zhan","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2025.103495_bib0008","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.1665","article-title":"The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models","volume":"28","author":"Shi","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"8","key":"10.1016\/j.retram.2025.103495_bib0009","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib","volume":"109","author":"Mulligan","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2025.103495_bib0010","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2011.53","article-title":"Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma","volume":"25","author":"Chng","year":"2011","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.retram.2025.103495_bib0011","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"issue":"3","key":"10.1016\/j.retram.2025.103495_bib0012","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Irizarry RA. affy\u2013analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.retram.2025.103495_bib0013","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.retram.2025.103495_bib0014","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"10.1016\/j.retram.2025.103495_bib0015","first-page":"387","article-title":"Identification of candidate genes and therapeutic agents for light chain amyloidosis based on bioinformatics approach","volume":"12","author":"Bai","year":"2019","journal-title":"Pharmacogenomics Pers Med"},{"issue":"29","key":"10.1016\/j.retram.2025.103495_bib0016","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1200\/JCO.21.02614","article-title":"Second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma: a European myeloma network (EMN) report within the HARMONY project","volume":"40","author":"D'Agostino","year":"2022","journal-title":"J Clin oncol: Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.retram.2025.103495_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051028","article-title":"CENPE inhibition leads to mitotic catastrophe and DNA damage in medulloblastoma cells","volume":"13","author":"Iegiani","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.retram.2025.103495_bib0018","doi-asserted-by":"crossref","first-page":"e56954","DOI":"10.1371\/journal.pone.0056954","article-title":"Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cells","volume":"8","author":"Nara","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.retram.2025.103495_bib0019","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/10428194.2020.1832659","article-title":"TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing","volume":"62","author":"Reale","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"51","key":"10.1016\/j.retram.2025.103495_bib0020","doi-asserted-by":"crossref","first-page":"e27690","DOI":"10.1097\/MD.0000000000027690","article-title":"FANCI may serve as a prognostic biomarker for cervical cancer: a systematic review and meta-analysis","volume":"100","author":"Liu","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.retram.2025.103495_bib0021","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3389\/fonc.2018.00615","article-title":"Development and validation of a 9-gene prognostic signature in patients with multiple myeloma","volume":"8","author":"Liu","year":"2018","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.retram.2025.103495_bib0022","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrm2774","article-title":"Kinesin superfamily motor proteins and intracellular transport","volume":"10","author":"Hirokawa","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5759","key":"10.1016\/j.retram.2025.103495_bib0023","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.1122142","article-title":"Chromosomes can congress to the metaphase plate before biorientation","volume":"311","author":"Kapoor","year":"2006","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.retram.2025.103495_bib0024","first-page":"2425","article-title":"A centromere-associated gene score for rapid determination of risk in multiple myeloma","volume":"12","author":"Bai","year":"2020","journal-title":"Am J Transl Res"},{"issue":"15","key":"10.1016\/j.retram.2025.103495_bib0025","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/onc.2016.368","article-title":"Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease","volume":"36","author":"van Andel","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.retram.2025.103495_bib0026","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2141.2002.03635.x","article-title":"Beta(2)-microglobulin as a negative growth regulator of myeloma cells","volume":"118","author":"Min","year":"2002","journal-title":"Br J Haematol"},{"issue":"509","key":"10.1016\/j.retram.2025.103495_bib0027","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan6282","article-title":"C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis","volume":"10","author":"Yang","year":"2017","journal-title":"Sci Signal"},{"issue":"8","key":"10.1016\/j.retram.2025.103495_bib0028","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1182\/blood-2007-03-081018","article-title":"Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group","volume":"111","author":"Ludwig","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.retram.2025.103495_bib0029","doi-asserted-by":"crossref","first-page":"931","DOI":"10.7326\/0003-4819-115-12-931","article-title":"Alexanian R. High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma","volume":"115","author":"Dimopoulos","year":"1991","journal-title":"Ann Intern Med"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:34:39Z","timestamp":1762626879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318625000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2452318625000042"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2025.103495","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying potential prognosis markers in relapsed multiple myeloma via integrated bioinformatics analysis and biological experiments","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2025.103495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103495"}}